SynthesisDrug safety2001
The use of analgesics in patients with asthma.
Synthesis in Drug safety, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.
- Risk of wheezing and asthma exacerbation in children treated with paracetamol versus ibuprofen: a systematic review and meta-analysis of randomised controlled trials.BMC pulmonary medicine · 2020Pooled it
- Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice.BMJ (Clinical research ed.) · 2004Pooled it
- Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study.Thorax · 2008Trial
- Immune Cells Mediate the Causal Pathway Linking Multisite Chronic Pain to Asthma: A Mediation Mendelian Randomization Study.Journal of pain research · 2025Article
- Asthma Is Associated with Back Pain and Migraine-Results of Population-Based Case-Control Study.Journal of clinical medicine · 2023Article
- Comparative Efficacy of Analdent (Herbal Analgesic Preparation) and Aceclofenac on Pain Intensity After Tooth Extraction: A Split-Mouth Randomized Clinical Trial.Journal of maxillofacial and oral surgery · 2023Article
- Use of pharmaceuticals amongst athletes tested by Anti-Doping Norway in a five-year period.Frontiers in sports and active living · 2023Article
- Frequency and Knowledge of Analgesics Self-Use and Their Adverse Effects in the Eastern Province of Saudi Arabia.Cureus · 2023Article
- Prenatal and infant paracetamol exposure and development of asthma: the Norwegian Mother and Child Cohort Study.International journal of epidemiology · 2016Article
- Aspirin and multiple sclerosis.BMC medicine · 2015Review
- Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children.The Journal of allergy and clinical immunology · 2015Article
- Pre- and post-operative management of dental implant placement. Part 1: management of post-operative pain.British dental journal · 2014Article
- The time delay between drug intake and bronchospasm for nonsteroidal antiinflammatory drugs sensitive patients.The World Allergy Organization journal · 2010Article
- Tolerability of paracetamol.Drug safety · 2005Review
- Aspirin induced asthma: clinical relevance of finding was not explained.BMJ (Clinical research ed.) · 2004Article
- Ibuprofen and increased morbidity in children with asthma: fact or fiction?Paediatric drugs · 2004Review
- National Athletic Trainers' Association position statement: management of asthma in athletes.Journal of athletic trainingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aspirin (acetylsalicylic acid) and other nonsteroidal anti-inflammatory drugs (NSAIDs) cause deterioration in respiratory function in approximately 10% of adults with asthma and a smaller proportion of children with asthma. We propose evidence-based guidelines for the safe use of NSAIDs in individuals with asthma following systematic review of data from the last 10 years relevant to the use of these drugs in such patients. We would currently recommend that patients with asthma who are known to be intolerant of NSAIDs or who exhibit any of the high risk clinical features for intolerance to these drugs (severe asthma, nasal polyps or chronic rhinosinusitis) should use NSAIDs only under close medical supervision. In those with high risk features formal aspirin provocation testing would be recommended prior to the therapeutic use of NSAIDs. Those individuals with asthma who regularly use NSAIDs can continue to do so but should be warned that intolerance to NSAIDs can develop late in life. Lack of relevant experimental evidence precludes the production of evidence-based guidelines for the group of patients with asthma who do not exhibit high risk clinical features and who have never before used NSAIDs. We would currently recommend that this group be treated as potentially intolerant to NSAIDs and use of these drugs can only be recommended under medical supervision but note that further studies and clinical experience could be expected to relax this restriction for many patients. Recent data have suggested that frequent use of paracetamol (acetaminophen) may contribute to a deterioration of respiratory function in asthma. A small proportion of patients with asthma who are NSAID-intolerant experience short-lived deterioration in respiratory function with the use of high doses of paracetamol but this is uncommon and has not been implicated in life-threatening reactions. Routine warnings about paracetamol use in asthma are, therefore, not warranted. Medical personnel, however, should be aware of the potential for worsening of symptoms in some individuals with asthma using paracetamol and institute formal investigation or withdrawal of the drug if they suspect such a reaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.